Harvey Philip D, Miller Michelle L, Moore Raeanne C, Depp Colin A, Parrish Emma M, Pinkham Amy E
Dr. Harvey is with the University of Miami Miller School of Medicine in Miami, Florida, and Research Service at Bruce W. Carter VA Medical Center in Miami, Florida.
Ms. Miller is with the University of Miami Miller School of Medicine in Miami, Florida.
Innov Clin Neurosci. 2021 Jan 1;18(1-3):24-30. eCollection 2021 Jan-Mar.
The development and deployment of technology-based assessments of clinical symptoms are increasing. This study used ecological momentary assessment (EMA) to examine clinical symptoms and relates these sampling results to structured clinical ratings. Three times a day for 30 days, participants with bipolar disorder (n=71; BPI) or schizophrenia (n=102; SCZ) completed surveys assessing five psychosis-related and five mood symptoms, in addition to reporting their location and who they were with at the time of survey completion. Participants also completed Positive and Negative Syndrome Scale (PANSS) interviews with trained raters. Mixed-model repeated-measures (MMRM) analyses examined diagnostic effects and the convergence between clinical ratings and EMA sampling. In total, 12,406 EMA samples were collected, with 80-percent adherence to prompts. EMA-reported psychotic symptoms manifested substantial convergence with equivalent endpoint PANSS items. Patients with SCZ had more severe PANSS and EMA psychotic symptoms. There were no changes in symptom severity scores as a function of the number of previous assessments. EMA surveyed clinical symptoms converged substantially with commonly used clinical rating scales in a large sample, with high adherence. This suggested that remote assessment of clinical symptoms is valid and practical and was not associated with alterations in symptoms as a function of reassessment, with additional benefits of "in the moment" sampling, such as eliminating recall bias and the need for informant reports.
基于技术的临床症状评估的开发和应用正在增加。本研究采用生态瞬时评估(EMA)来检查临床症状,并将这些抽样结果与结构化临床评分相关联。双相情感障碍患者(n = 71;BPI)或精神分裂症患者(n = 102;SCZ)每天三次,持续30天,完成评估五项与精神病相关症状和五项情绪症状的调查,此外还需报告他们在完成调查时的位置以及当时与谁在一起。参与者还与经过培训的评估者完成了阳性和阴性症状量表(PANSS)访谈。混合模型重复测量(MMRM)分析检查了诊断效果以及临床评分与EMA抽样之间的一致性。总共收集了12406个EMA样本,对提示的依从率为80%。EMA报告的精神病症状与等效的终点PANSS项目表现出高度一致性。SCZ患者的PANSS和EMA精神病症状更严重。症状严重程度评分不会因先前评估的次数而改变。在一个大样本中,EMA调查的临床症状与常用临床评分量表高度一致,且依从性高。这表明对临床症状的远程评估是有效且实用的,并且与作为重新评估函数的症状改变无关,还具有“即时”抽样的额外优势,例如消除回忆偏差和对信息提供者报告的需求。